SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies files DRHP with SEBI

01 Jan 2016 Evaluate

Diagnostics Company Thyrocare Technologies has filed draft red herring prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for an initial public offering (IPO) of 10.7 million shares. The company is planning to raise $85 million to $100 million through a stock market listing.

Thyrocare is planning to list on both the BSE and NSE exchanges. JM Financial, Edelweiss Financial, ICICI Securities are lead managers for the issue.

Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in more than 2000 cities / towns in India and internationally. Thyrocare operates with a Centralized Processing Laboratory (CPL) in Mumbai - India for esoteric tests; and Regional Processing Laboratory in major metro cities of India and other parts of Asia.

Thyrocare Tech. Share Price

394.30 4.90 (1.26%)
20-Apr-2026 14:36 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×